LEO Pharma, a leader in medical dermatology, has refinanced its syndicated loan facility of Dkr11.2bn (US$1.7bn). The refinancing, facilitated by a consortium of Nordic banks, marks the company’s inaugural sustainability-linked…
LEO Pharma, a leader in medical dermatology, has refinanced its syndicated loan facility of Dkr11.2bn (US$1.7bn). The refinancing, facilitated by a consortium of Nordic banks, marks the company’s inaugural sustainability-linked…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference